Kramer M, Mele F, Jovic S, Fernandez B, Jarrossay D, Low J
J Clin Invest. 2025; 135(2.
PMID: 39817450
PMC: 11735102.
DOI: 10.1172/JCI183776.
Chen X, Ghanizada M, Mallajosyula V, Sola E, Capasso R, Kathuria K
Nat Immunol. 2025; 26(2):230-239.
PMID: 39806065
PMC: 11785521.
DOI: 10.1038/s41590-024-02062-x.
Beckers D, Jainarayanan A, Dustin M, Capera J
Immune Netw. 2025; 24(6):e42.
PMID: 39801736
PMC: 11711127.
DOI: 10.4110/in.2024.24.e42.
Brambley C, Baker B
Nat Immunol. 2025; 26(1):9-10.
PMID: 39747432
DOI: 10.1038/s41590-024-02039-w.
Lu B, Lucca L, Lewis W, Wang J, Nogueira C, Heer S
Nat Immunol. 2024; 26(1):82-91.
PMID: 39609626
DOI: 10.1038/s41590-024-02023-4.
PD-1 and CD73 on naive CD4 T cells synergistically limit responses to self.
Nettersheim F, Brunel S, Sinkovits R, Armstrong S, Roy P, Billitti M
Nat Immunol. 2024; 26(1):105-115.
PMID: 39572641
PMC: 11697576.
DOI: 10.1038/s41590-024-02021-6.
Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response.
Tan L, Yin T, Xiang H, Wang L, Mudgal P, Chen J
Nat Commun. 2024; 15(1):8569.
PMID: 39362877
PMC: 11450162.
DOI: 10.1038/s41467-024-52902-5.
Understanding vertebrate immunity through comparative immunology.
Boehm T
Nat Rev Immunol. 2024; 25(2):141-152.
PMID: 39317775
DOI: 10.1038/s41577-024-01083-9.
Toxicity in the era of immune checkpoint inhibitor therapy.
Keam S, Turner N, Kugeratski F, Rico R, Colunga-Minutti J, Poojary R
Front Immunol. 2024; 15:1447021.
PMID: 39247203
PMC: 11377343.
DOI: 10.3389/fimmu.2024.1447021.
Tissue determinants of the human T cell receptor repertoire.
Sureshchandra S, Henderson J, Levendosky E, Bhattacharyya S, Kastenschmidt J, Sorn A
bioRxiv. 2024; .
PMID: 39229002
PMC: 11370363.
DOI: 10.1101/2024.08.17.608295.
Myasthenia gravis: the future is here.
Kaminski H, Sikorski P, Coronel S, Kusner L
J Clin Invest. 2024; 134(12).
PMID: 39105625
PMC: 11178544.
DOI: 10.1172/JCI179742.
Gamma-aminobutyric acid for delaying type 1 diabetes mellitus: an update.
Sutedja J, de Liyis B, Saraswati M
Ann Pediatr Endocrinol Metab. 2024; 29(3):142-151.
PMID: 38956751
PMC: 11220392.
DOI: 10.6065/apem.2346184.092.
The CD8 T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects.
Van Der Byl W, Nussing S, Peters T, Ahn A, Li H, Ledergor G
Immunity. 2024; 57(6):1324-1344.e8.
PMID: 38776918
PMC: 11807353.
DOI: 10.1016/j.immuni.2024.04.026.
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy.
Lischer C, Eberhardt M, Flamann C, Berges J, Guse E, Wessely A
J Immunother Cancer. 2024; 12(5).
PMID: 38724462
PMC: 11086525.
DOI: 10.1136/jitc-2023-008104.
A journey to your self: The vague definition of immune self and its practical implications.
Koncz B, Balogh G, Manczinger M
Proc Natl Acad Sci U S A. 2024; 121(23):e2309674121.
PMID: 38722806
PMC: 11161755.
DOI: 10.1073/pnas.2309674121.
Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy.
Kellermann G, Leulliot N, Cherfils-Vicini J, Blaud M, Brest P
Front Immunol. 2024; 15:1382236.
PMID: 38571942
PMC: 10989059.
DOI: 10.3389/fimmu.2024.1382236.
Breaking tolerance: the autoimmune aspect of atherosclerosis.
Khan A, Roy P, Ley K
Nat Rev Immunol. 2024; 24(9):670-679.
PMID: 38472321
PMC: 11682649.
DOI: 10.1038/s41577-024-01010-y.
How persistent infection overcomes peripheral tolerance mechanisms to cause T cell-mediated autoimmune disease.
Yin R, Melton S, Huseby E, Kardar M, Chakraborty A
Proc Natl Acad Sci U S A. 2024; 121(11):e2318599121.
PMID: 38446856
PMC: 10945823.
DOI: 10.1073/pnas.2318599121.
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.
Zhao X, Ju B, Xiu N, Sun X, Meng F
Front Immunol. 2024; 15:1339971.
PMID: 38426096
PMC: 10902444.
DOI: 10.3389/fimmu.2024.1339971.
B cell-reactive triad of B cells, follicular helper and regulatory T cells at homeostasis.
Lin Y, Wan Z, Liu B, Yao J, Li T, Yang F
Cell Res. 2024; 34(4):295-308.
PMID: 38326478
PMC: 10978943.
DOI: 10.1038/s41422-024-00929-0.